Just Health PR wins Caris Life Sciences brief

Just Health PR has won a brief with the US-based biosciences company Caris Life Sciences, focusing on its molecular intelligence services division.

The medical firm is seeking to bring its tumour profiling technology to the UK and EU market and has therefore partnered with Just Health PR, marking its first contract with a dedicated comms and public affairs agency in Europe.

Caris' service takes genetic information from patients and cross-references the data with existing scientific literature to help doctors and clinicians determine which therapies would be best suited to their needs.

Just Health PR has been tasked with raising awareness of this service and has already commenced talks with the Department of Health, the NHS Technology Adoption Centre and the Downing Street Policy Unit on how the NHS could utilise it.

The agency's head of political relations John Spiers said: "We are thrilled to be working on a technology which has the potential to revolutionise the way we treat cancer."

Caris Life Sciences joins companies such as AstraZeneca, Shire, Novartis, Pfizer and GlaxoSmithKline on Just Health PR's client roster.